Physician profile
Gregory Jacob
NPI 1629430269
$8,650.92
in general payments reported to CMS, 2019-2025
18 companies · $694 in 2025
The $694 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.89 · 2020: $30.00 · 2021: $49.56 · 2022: $82.42 · 2023: $7,393 · 2024: $363 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,012 · Food and Beverage: $1,355 · Travel and Lodging: $1,083.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,011.85 |
| Food and Beverage | $1,354.63 |
| Travel and Lodging | $1,082.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,145.07 | 2023 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $314.56 | 2023-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $308.54 | 2023-2025 | Tezspire, Airsupra, Fasenra |
| Genzyme Corporation | $205.67 | 2024-2025 | |
| United Therapeutics Corporation | $182.37 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.47 | 2025 | |
| Viatris Specialty LLC | $73.15 | 2025 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $70.86 | 2024-2025 | Uptravi |
| Stryker Corporation | $49.56 | 2021 | |
| Merz North America, INC. | $30.00 | 2020 | |
| Baxter Healthcare | $23.64 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Tempus Ai, INC | $22.46 | 2024 | |
| Insmed, INC. | $18.24 | 2025 | Arikayce |
| Inogen, INC. | $15.91 | 2025 | |
| Lilly USA, LLC | $14.53 | 2025 | Zepbound |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.53 | 2019 | |
| Vifor Pharma, INC. | $13.11 | 2019 | |
| Abbvie INC. | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.